SynthesisFrontiers in neurology2025
Constipation and risk of cognitive impairment and dementia in adults: a systematic review and meta-analysis.
Synthesis in Frontiers in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Gut Microbiota in Constipation and Mild Cognitive Impairment: A Mendelian Randomization and Observational Study of Two Common Geriatric Syndromes.Clinical interventions in aging · 2026Observational
- Nomogram to predict 5-year global cognitive impairment inFrontiers in neuroscience · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: It has been shown that constipation may have a close association with the occurrence of cognitive impairment (CI). This study was aimed at assessing the risk of CI in patients with constipation and exploring the interactions of constipation with other factors affecting CI. Methods: Embase, PubMed, Web of Science, and Cochrane were systematically searched to collect relevant literature for assessment of the association between constipation and CI. The included studies was subjected to quality assessment using the NIH quality assessment tool for observational cohort and cross-sectional studies. An odds ratio (OR) was calculated using a random effects model, and subgroup and sensitivity analyses were performed. Publication bias was assessed by the Egger's test and funnel plot, with a Results: A total of 11 studies were included, including five retrospective studies and six cross-sectional studies, with 66,609 participants involved. The OR between constipation and cognitive impairment was 1.11 (95% CI: 1.03-1.20). Subgroup analysis showed that the OR between constipation and CI was 1.33 (95% CI: 1.12-1.58) in patients with Parkinson's disease and 1.05 (95% CI: 0.98-1.13) in patients without Parkinson's disease. The OR was 1.37 (95% CI: 1.07-1.74) in retrospective studies and 1.06 (95% CI: 0.98-1.15) in cross-sectional studies. The OR was 1.29 (95% CI: 0.92-1.80) in Europe and 1.12 (95% CI: 1.04-1.22) in Asia. Conclusion: The risk of CI was 1.11 times higher in constipated patients than in non-constipated patients. Constipation might significantly increase the risk of CI, especially in patients with Parkinson's disease. Systematic review registration: https://www.crd.york.ac.uk/PROSPERO/view/CRD42025630902, identifier: CRD42025630902.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.